Arrowhead Pharmaceuticals Inc ARWR

US Biotechnology

$84.65 ▼ -3.06% ($-2.67)

⬇️ Below Yest. Low 📅 Earnings This Week

Open $86.93

Prev Close $87.32

Day Range $84.53 – $87.10

52W Range $15.01 – $95.49

Market Cap $11.92B

Beta 1.28

EPS (TTM) $-2.15

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1993-12-14
Shares Out.	140,860,000
Website	arrowheadpharma.com/ ↗
Phone	13026974590
Employees	711
Revenue	$73.7M
Gross Profit	$73.7M
Net Income	-$137.6M
Free Cash Flow	-$50.9M
Total Assets	$2.27B
Total Liabilities	$1.67B
Equity	$598.9M

About Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Arrowhead Pharmaceuticals Inc is a publicly traded company under the ticker symbol ARWR on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.